Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Q3DI
|
|||
| Former ID |
DNC013398
|
|||
| Drug Name |
3-methoxy-5-(1,5-naphthyridin-3-yl)benzonitrile
|
|||
| Synonyms |
CHEMBL397617; 3-methoxy-5-(1,5-naphthyridin-3-yl)benzonitrile
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H11N3O
|
|||
| Canonical SMILES |
COC1=CC(=CC(=C1)C2=CC3=C(C=CC=N3)N=C2)C#N
|
|||
| InChI |
1S/C16H11N3O/c1-20-14-6-11(9-17)5-12(7-14)13-8-16-15(19-10-13)3-2-4-18-16/h2-8,10H,1H3
|
|||
| InChIKey |
KPRNNBVYUUWBLA-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis and SAR comparison of regioisomeric aryl naphthyridines as potent mGlu5 receptor antagonists. Bioorg Med Chem Lett. 2007 Dec 1;17(23):6525-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.